What about Urinary Tract Infections and its Antibiotic Resistance Bacteria in Ilam, Iran?

Title:What about Urinary Tract Infections and its Antibiotic Resistance Bacteria in Ilam, Iran?

Volume: 18 Issue: 3

Author(s): Khadijeh Esmaili, Reza Mohebi, Nourkhoda Sadeghifard, Morovat Taherikalani, Iraj Pakzad, Abbas Maleki, Hasan Valadbeigi and Sobhan Ghafourian*

Affiliation:

• Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam,Iran

Keywords: Antibiotic resistance, Nosocomial infection, E. coli, Antibiotic resistance, Bacteria, Urinary tract infections.

Abstract: Background: Because of the unknown situation of antibiotic resistance pattern in the main hospital in Ilam, Iran, we aimed to evaluate the antibiotic resistance pattern of uropathogenic bacteria obtained from referred patients to Imam Khomaini Hospital, Ilam, Iran. So, 114 bacteria were collected during 9-month period and evaluated for their antibiotic resistance patterns.

Results: Our results demonstrated that Escherichia coli as the dominant responsible for urinary tract infection. Our results demonstrated that 61.4 % (n = 70) of isolates were positive for E.coli, while lowest prevalence was observed for Staphylococcus aureus and Acinetobacter baumannii. The results also showed that 6.4% (n = 7) were metallo beta lactamase (MBL) producers. Our findings showed only 4 gram positive bacteria were obtained from patients with urinary tract infections including one methicillin resistant S. aureus (MRSA) and 2 vancomycin resistant Enterococcus faecalis (VRE).

Conclusion: In conclusion, we strongly recommended to perform a perfect study among all hospitals in Iran to evaluate the situation of antibiotic resistance and make a real panel to control this issue.

Cite this article as:

Esmaili Khadijeh , Mohebi Reza , Sadeghifard Nourkhoda , Taherikalani Morovat , Pakzad Iraj , Maleki Abbas , Valadbeigi Hasan and Ghafourian Sobhan *, What about Urinary Tract Infections and its Antibiotic Resistance Bacteria in Ilam, Iran?, Infectious Disorders - Drug Targets 2018; 18 (3) . https://dx.doi.org/10.2174/1871526518666180622162229